hVIVO Year in Review 2024

(3:44)

hVIVO Year in Review: Milestones, Growth and 2025 Ambitions

(9:14)

hVIVO year in review: bigger and better

(8:41)

Year in Review 2022 - hVIVO Group

(2:11)

hVIVO signs £11.5M RSV trial contract; expands services at new facility

(6:12)

hVIVO PLC - Full Year Results

(1:2:10)

hVIVO's hMPV Challenge Model Update

(4:30)

hVIVO Careers - Fueling Scientific Research

(2:26)

hVIVO PLC - Full Year Results

(1:2:39)

Year in Review 2021 - Open Orphan

(2:1econd)

Q\u0026A with hVIVO’s Mo Khan

(5:49)

hVIVO Whitechapel Clinic

(35)

Chief Scientific Officer, Dr Andrew Catchpole, discusses how hVIVO manufacture challenge agents

(2:58)

VP of Clinical Operations on hVIVO's new Facility

(1:51)

Year in Review 2023

(2:15)

hVIVO achieves record revenue and initiates dividend policy following successful year

(8:58)

hVIVO secures record £2.7M laboratory services contract, expanding global impact in virology

(4:41)

FluCamp Clinical Trials by hVIVO

(1:7)

hVIVO's Mo Khan on the company’s breakthrough year

(10:48)